Kilitch Drugs Share Price Today | Stock Price & Kilitch Drugs Share Screener

Track the current stock price of Kilitch Drugs with an interactive chart. Analyse KILITCH share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Kilitch Drugs stock quote in one place.

The quote of ₹233.74 sits between the 52-week low of ₹124.45 and the 52-week high of ₹400.25, and the latest session moved 6.97% from the previous close.

Screen Kilitch Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KILITCH shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE729D01010.

Classification

Identifiers and Leadership

Screen KILITCH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹458, up from ₹313 in 2025.

Latest statistics put total assets at ₹458 and shareholder funds at ₹277, with a leverage ratio of 0.29.

Screen Kilitch Drugs income statement and profit fundamentals. Analyze KILITCH quarterly results. Kilitch Drugs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹90 and net profit was ₹15, equal to earnings per unit of ₹4.24, at an operating margin of 25%.

In that period expenses were ₹68, interest cost ₹1 and tax ₹5. The next period listed, 2026-Jun, shows revenue of ₹48 and net profit of ₹2.

Screen KILITCH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹24, and net cash flow was an inflow of ₹6.

Over the same period, investing activities used ₹100 and financing activities provided ₹82.

See Kilitch Drugs shareholding pattern with promoter, FII, and DII holdings. Check Kilitch Drugs promoter holding and ownership changes for KILITCH on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 63.77%, foreign institutions 0.00%, domestic institutions 0.00% and the public 29.70%, spread across 11,642 shareholders.

The shareholder count was 11,642 in 2026-Mar, compared with 12,627 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Kilitch Drugs. Kilitch Drugs dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

See which indices include Kilitch Drugs stock. Check KILITCH index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Kilitch Drugs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Kilitch Drugs stock events that may affect KILITCH share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Annual General Meeting dated August 27, 2026, with a record date of August 27, 2026.

It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 15, 2026.

Screen KILITCH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen KILITCH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 29, 2026.

The next most recent announcements are dated August 27, 2026 and August 27, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.